Why This Chicago Progressive Had to Delete Her Account Following This Post
Here's Why Trump's Ukraine Strategy Is Better Than Biden's
JD Vance Didn't Hold Back on Bolton, Ukraine, and Crime in This Interview
Gavin’s Limpy Bluster
Arizona Charges 170 in Immigration Sweep
CNN Admits the Brutal Truth: Democrats Are Bleeding Voters
Trump Will Send Troops to Baltimore if It Needs Help
Chinese Scammer Sentenced to 24 Months in Prison
DeSantis Defends Removal of Rainbow LGBT Crosswalk
Boston Cops Defy Left-Wing Mayor Michelle Wu, Secretly Aid ICE in Arresting Criminal...
Vivek Ramaswamy Surges Ahead in Ohio Governor's Race
FBI's 'Summer Heat' Initiative Under Trump to Make the U.S. Safe Again
California’s Homeless Crisis: Two Decades of Empty Promises Under Newsom’s Watch
When Envy Becomes a Political Weapon
Socialist Zohran Mamdani’s Muscle Showdown Falls Flat as Social Media Roasts His Bench...
Tipsheet

The Results Are in: Pfizer’s Clinical Trial with Young Adults

AP Photo/Mark Lennihan

It's possible that teens and pre-teens may be able to go back to school this fall vaccinated. Pfizer has released the results of clinical trial on young adults aged 12 to 15. Albeit it was a small study, but it was extremely successful. As in 100 percent successful. 

Advertisement

In a study of 2,260 volunteers, "preliminary data showed there were no cases of COVID-19 among fully vaccinated adolescents compared to 18 among those given dummy shots," Pfizer reported, according to the Associated Press.

The subjects experienced the same side effects as adults, including pain, fever, chills and fatigue.

"We share the urgency to expand the use of our vaccine,” Pfizer CEO Albert Bourla said in a statement. He expressed “the hope of starting to vaccinate this age group before the start of the next school year” in the United States. 

Advertisement

As of now, Pfizer is only approved for individuals 16 and up.

With the encouraging results, Pfizer and BioNTech plan to ask the Food and Drug Administration for approval within the coming weeks.

There are currently three FDA approved coronavirus vaccines: Pfizer-BioNTech, Moderna and Johnson & Johnson. J&J is the only one that requires only one dose. 

Moderna is also planning to conduct a study of 12 to 17-year-olds.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement